Genprex Inc
For the period ended Dec 31, 2023. Filed Apr 1, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Apr 1, 2024
GNPX$2.06-0.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets
| Year Ended | ||
|---|---|---|
| December 31, | ||
| 2023 | 2022 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $6,737,629 | $20,954,069 |
| Accounts receivable | — | 34,852 |
| Prepaid expenses and other | 794,138 | 484,224 |
| Total current assets | 7,531,767 | 21,473,145 |
| Property and equipment, net | 7,859 | 23,032 |
| Other assets: | ||
| Security deposits | 10,000 | 21,818 |
| Research and development supplies | 2,347,488 | 2,864,937 |
| Intellectual property, net | 773,478 | 702,095 |
| Total other assets | 3,130,966 | 3,588,850 |
| Total assets | $10,670,592 | $25,085,027 |
| Liabilities and Stockholders' Equity | ||
| Current liabilities: | ||
| Accounts payable | $1,397,610 | $442,925 |
| Other current liabilities | 1,856,598 | 2,367,362 |
| Total current liabilities | 3,254,208 | 2,810,287 |
| Stockholders' equity: | ||
| Common stock $0.001 par value: 200,000,000 shares authorized; 1,485,902 and 1,202,677 shares issued and outstanding, respectively | 1,486 | 1,203 |
| Additional paid-in capital | 141,103,178 | 125,101,356 |
| Accumulated deficit | (133,688,280) | (102,827,819) |
| Total stockholders' equity | 7,416,384 | 22,274,740 |
| Total liabilities and stockholders' equity | $10,670,592 | $25,085,027 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.